IDL Biotech AB continues preparations to introduce its rapid test for bladder cancer, UBC Rapid, in the US. | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Latest News

September 2019

IDL Biotech AB continues preparations to introduce its rapid test for bladder cancer, UBC Rapid, in the US.

IDL Biotech has started the work on mapping the US market.

Read more here 

IDL signed two new distributions agreements

IDL has signed two new distributions agreements.

IDL Biotech knyter till sig världskänd Vetenskaplig Rådgivare

IDL Biotech fortsätter förstärka sitt globala team. Sam Kariuki, med över trettio års erfarenhet inom tropisk medicin, är ny Vetenskaplig Rådgivare till bolaget.

IDL Biotech

Skip this intro